Ampio Pharmaceuticals, Inc.

États‑Unis d’Amérique

 
Quantité totale PI 33
Quantité totale incluant filiales 36 (+ 3 pour les filiales)
Rang # Quantité totale PI 43 616
Note d'activité PI 2,1/5.0    16
Rang # Activité PI 53 321
Symbole boursier
ISIN US03209T1097
Capitalisation 131M  (USD)
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

18 1
0 0
13 0
1
 
Dernier brevet 2022 - Methods of treating viral diseases
Premier brevet 1989 - Detection of appendicitis by mea...
Dernière marque 2013 - AMPIO PHARMACEUTICALS
Première marque 2013 - AMPIO PHARMACEUTICALS

Filiales

1 subsidiaries with IP (3 patents, 0 trademarks)

 S'inscrire grtuitement pour accéder à la liste des filiales

Industrie (Classification de Nice)

Derniers inventions, produits et services

2022 Invention Treatment of t-cell mediated diseases. The invention provides a method of treating T-cell mediat...
Invention Methods of treating viral diseases. The present disclosure provides methods of treating a TLR7- a...
Invention Methods for treating diseases associated with respiratory viruses. The present disclosure provid...
2021 Invention Methods for treating diseases associated with respiratory viruses. The present disclosure provide...
Invention Treatment of joint conditions. The invention provides a method of treating a joint condition. Th...
Invention Implantable medical devices with increased immune tolerance, and methods for making and implantin...
Invention Compositions for the mobilization, homing, expansion and differentiation of stem cells and method...
2020 Invention Treatment of rhinitis. The invention provides a method of treating rhinitis. The method comprise...
Invention Treatment of diseases. The invention provides a method of inhibiting vascular hyperpermeability ...
Invention Treatment of t-cell mediated diseases. The invention provides a method of treating T-cell mediate...
Invention Treatment of degenerative joint disease. The invention provides a method of treating a degenerat...
Invention Treatment of disease with n-acetyl kynurenine. The invention provides a method, composition and k...
2019 Invention Treatment of joint conditions. The invention provides a method of treating a joint condition. The...
Invention Treatment of degenerative joint disease. The invention provides a method of treating a degenerati...
2017 Invention Treatment of disease with n-acetyl kynurenine. The invention provides a method, composition and ...
Invention Treatment of diseases mediated by vascular hyperpermeability. The invention provides a method of...
Invention Treatment of diseases mediated by vascular hyperpermeability. The invention provides a method of ...
Invention Treament of t-cell mediated diseases. The invention provides a method of treating T-cell mediate...
2016 Invention Method of using diketopiperazines and composition containing them. The invention provides a metho...
Invention Use of low molecular weight fractions of human serum albumin in treating diseases. The present in...
Invention Methods of treatment of diseases. The invention provides a method of inhibiting vascular hyperper...
2015 Invention Method for treatment of diseases. The invention provides a method of inhibiting vascular hyperper...
Invention Methods and products for treatment of diseases. The invention provides a method of treating a di...
2014 Invention Therapeutic methods and compounds. The invention provides diketopiperazines of formula I. The inv...
Invention Methods for producing diketopiperazines and compositions containing diketopiperazines. Methods o...
2013 P/S Pharmaceutical preparations for the treatment of conditions caused by vascular hyperpermeability;...
P/S Pharmaceutical preparations for the treatment of inflammation Research and development of pharmac...
2012 Invention Treatment of rhinitis. The invention provides a method of treating rhinitis. The method comprises...